Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Evolving therapies for lower-risk myelodysplastic syndromes Apr 2020 Annals of Hematology Myelodysplastic Syndromes (MDS)
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia Aug 2024 Annals of Hematology Aplastic Anemia
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia Jul 2023 Annals of Hematology Aplastic Anemia
Quality of life after immune suppressive therapy in aplastic anemia Apr 2024 Annals of Hematology Aplastic Anemia
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry May 2020 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia Sep 2024 Annals of Hematology Aplastic Anemia
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database Apr 2025 Annals of Hematology Aplastic Anemia
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists Nov 2024 Annals of Hematology Myelodysplastic Syndromes (MDS)
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria? May 2025 Annals of Hematology Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH)
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Oct 2019 Annals of Hematology Myelodysplastic Syndromes (MDS)